Format

Send to

Choose Destination
See comment in PubMed Commons below
JAMA. 2017 Sep 5;318(9):793-794. doi: 10.1001/jama.2017.10697.

Considerations on the Off-label Use of Ketamine as a Treatment for Mood Disorders.

Author information

1
Department of Psychiatry, Yale School of Medicine, New Haven, Connecticut.
2
The Yale Psychiatric Hospital, Yale New Haven Health, New Haven, Connecticut.
PMID:
28806440
DOI:
10.1001/jama.2017.10697
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Silverchair Information Systems
    Loading ...
    Support Center